California Public Employees Retirement System lowered its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) by 2.8% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 631,534 shares of the company’s stock after selling 18,250 shares during the period. California Public Employees Retirement System’s holdings in Neurocrine Biosciences were worth $75,430,000 at […]
Neurocrine Biosciences (NASDAQ:NBIX – Get Rating) had its target price cut by Barclays from $131.00 to $125.00 in a research note issued to investors on Thursday, The Fly reports. Several other research analysts have also recently issued reports on NBIX. StockNews.com initiated coverage on Neurocrine Biosciences in a report on Thursday, March 16th. They issued […]
TD Asset Management Inc reduced its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) by 72.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 38,158 shares of the company’s stock after selling 99,494 shares during the quarter. TD Asset Management Inc’s holdings in Neurocrine Biosciences were worth $4,558,000 at the end […]
Neurocrine Biosciences (NASDAQ:NBIX – Get Rating) had its target price decreased by Mizuho from $116.00 to $111.00 in a research note released on Thursday, The Fly reports. Other research analysts also recently issued reports about the company. Evercore ISI upgraded Neurocrine Biosciences from an in-line rating to an outperform rating and set a $130.00 target […]
Handelsbanken Fonder AB lowered its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) by 13.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 13,167 shares of the company’s stock after selling 2,100 shares during the period. Handelsbanken Fonder AB’s holdings in Neurocrine Biosciences were worth […]